GLP-1 RA drugs help treat diabetes by weight loss, improving blood glucose levels and increasing insulin sensitivity, low ...

Patients taking the anti-obesity drugs had about 12% lower risk of hospital re-admission within a month of surgery, compared ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

I applaud the Biden administration’s recent moves to make these anti-obesity drugs more accessible to people on Medicaid and ...

The results also showed that the patients taking the GLP-1 RA drugs have a 12 per cent lower risk of hospital re-admission ...

Team also found 29 per cent lower risk of wound re-opening within six months of surgery, and about 56 per cent lower risk of ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Two of President-elect Trump’s top health nominees are on a collision course as the incoming administration faces a crucial ...

Immuno-oncology (IO) drugs used to treat cancer boost the immune response to a disease. Immunotherapy treatment uses a person’s immune system to fight cancer with monoclonal antibodies ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...